TY - JOUR
T1 - Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours
AU - Arena, Monica
AU - Masci, Enzo
AU - Eusebi, Leonardo Henry
AU - Iabichino, Giuseppe
AU - Mangiavillano, Benedetto
AU - Viaggi, Paolo
AU - Morandi, Elisabetta
AU - Fanti, Lorella
AU - Granata, Antonino
AU - Traina, Mario
AU - Testoni, Pier Alberto
AU - Opocher, Enrico
AU - Luigiano, Carmelo
PY - 2016/9/7
Y1 - 2016/9/7
N2 - Background: Hemospray is a new endoscopic haemostatic powder that can be used in the management of upper gastrointestinal bleedings. Aims: To assess the efficacy and safety of Hemospray as monotherapy for the treatment of acute upper gastrointestinal bleeding due to cancer. Methods: The endoscopy databases of 3 Italian Endoscopic Units were reviewed retrospectively and 15 patients (8 males; mean age 74 years) were included in this study. Results: Immediate haemostasis was achieved in 93% of cases. Among the successful cases, 3 re-bled, one case treated with Hemospray and injection had a good outcome, while 2 cases died both re-treated with Hemospray, injection and thermal therapy. No complications related to Hemospray occurred. Finally, 80% of patients had a good clinical outcome at 30. days and 50% at six months. Conclusion: Hemospray may be considered an effective and safe method for the endoscopic management of acute neoplastic upper gastrointestinal bleedings.
AB - Background: Hemospray is a new endoscopic haemostatic powder that can be used in the management of upper gastrointestinal bleedings. Aims: To assess the efficacy and safety of Hemospray as monotherapy for the treatment of acute upper gastrointestinal bleeding due to cancer. Methods: The endoscopy databases of 3 Italian Endoscopic Units were reviewed retrospectively and 15 patients (8 males; mean age 74 years) were included in this study. Results: Immediate haemostasis was achieved in 93% of cases. Among the successful cases, 3 re-bled, one case treated with Hemospray and injection had a good outcome, while 2 cases died both re-treated with Hemospray, injection and thermal therapy. No complications related to Hemospray occurred. Finally, 80% of patients had a good clinical outcome at 30. days and 50% at six months. Conclusion: Hemospray may be considered an effective and safe method for the endoscopic management of acute neoplastic upper gastrointestinal bleedings.
KW - Hemospray
KW - New endoscopic hemostatic treatment
KW - Upper gastrointestinal cancer
KW - Upper gastrointestinal neoplastic bleeding
UR - http://www.scopus.com/inward/record.url?scp=85008517913&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008517913&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2016.12.012
DO - 10.1016/j.dld.2016.12.012
M3 - Article
AN - SCOPUS:85008517913
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
SN - 1590-8658
ER -